FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 328:1418-1420 May 13, 1993 Number 19 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited

To the Editor: We believe Shapiro et al. (Dec. 17 issue)¹ had inadequate evidence to support their recommendation for nontreatment of deer-tick bites. The population samples were much too small for a meaningful comparison of the risks of serious late sequelae with the risks and benefits of prophylactic antibiotic therapy.

Consider the hypothetical situation of 10,000 deer-tick bites in Connecticut, in which 120 people would acquire the disease and 15 to 36 would not manifest erythema migrans. Magid et al.² estimate that 60 percent of these people would acquire chronic arthritis, 17 percent meningoencephalitis or neuropathy, and 6 percent cardiac . . . [Full Text of this Article]

References

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.